SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-232871
Filing Date
2018-07-31
Accepted
2018-07-31 13:25:46
Documents
9
Period of Report
2018-07-31

Document Format Files

Seq Description Document Type Size
1 6-K d451116d6k.htm 6-K 12188
2 EX-99.1 d451116dex991.htm EX-99.1 1138241
3 EX-99.2 d451116dex992.htm EX-99.2 64486
4 GRAPHIC g451116g01n22.jpg GRAPHIC 240751
5 GRAPHIC g451116g0731143716677.jpg GRAPHIC 2139
6 GRAPHIC g451116g10d25.jpg GRAPHIC 190755
7 GRAPHIC g451116g14t55.jpg GRAPHIC 177795
8 GRAPHIC g451116g40n70.jpg GRAPHIC 293294
9 GRAPHIC g451116g71l50.jpg GRAPHIC 210641
  Complete submission text file 0001193125-18-232871.txt   2751791
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 18980510
SIC: 2834 Pharmaceutical Preparations